Paul Schneider
Financieel Directeur/CFO bij FREELINE THERAPEUTICS HOLDINGS PLC
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Michael Parini | M | 49 | 3 jaar | |
| Chris Hollowood | M | 50 | 9 jaar | |
| James Bircher | M | 56 | 3 jaar | |
| Markus Hörer | M | - | 9 jaar | |
| Naomi Aoki | F | - | - | |
| Chip McCorkle | M | - | - | |
| Robin A. Walker | M | 55 |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC discovers, develops, and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders and autoimmune disease. The joint venture company is based in Cambridge, MA. | 7 jaar |
| Pamela Foulds | M | 55 | 3 jaar | |
| Henning R. Stennicke | M | 57 | 2 jaar | |
| Amy J. Spandau | F | - | 2 jaar | |
| Arne Naeveke | M | - | 2 jaar | |
| Nicole Jones | F | 54 | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Amit Chunilal Nathwani | M | 64 | 8 jaar | |
| Julia Gregory | F | 71 | - | |
| Colin Love | M | 65 | 3 jaar | |
| Jeffrey Chodakewitz | M | 68 | - | |
| Martin Andrews | M | 61 | - | |
| Stephen P. Diamond | M | - | 1 jaar | |
| Stephen Kennedy | M | 67 |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC discovers, develops, and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders and autoimmune disease. The joint venture company is based in Cambridge, MA. | - |
| Andrew Scharenberg | M | - |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC discovers, develops, and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders and autoimmune disease. The joint venture company is based in Cambridge, MA. | 2 jaar |
| Alan Brooks | M | 58 |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC discovers, develops, and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders and autoimmune disease. The joint venture company is based in Cambridge, MA. | 2 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigd Koninkrijk | 17 | 80.95% |
| Verenigde Staten | 4 | 19.05% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Paul Schneider
- Persoonlijk netwerk
